AAAAAA
Results: 1-25/43
Authors:
Wieser, R
Schreiner, U
Pirc-Danoewinata, H
Aytekin, M
Schmidt, HH
Rieder, H
Fonatsch, C
Citation: R. Wieser et al., Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies, GENE CHROM, 32(4), 2001, pp. 373-380
Authors:
Fonatsch, C
Nowotny, H
Pittermann-Hocker, E
Streubel, B
Jager, U
Valent, P
Buchner, T
Lechner, K
Citation: C. Fonatsch et al., Amplification of ribosomal RNA genes in acute myeloid leukemia, GENE CHROM, 32(1), 2001, pp. 11-17
Authors:
Laczika, K
Mitterbauer, G
Mitterbauer, M
Knobl, P
Schwarzinger, I
Greinix, HT
Rabitsch, W
Fonatsch, C
Mannhalter, C
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions, LEUK LYMPH, 42(5), 2001, pp. 923-931
Authors:
Sperr, WR
Wimazal, F
Kundi, M
Fonatsch, C
Thalhammer-Scherrer, R
Schernthaner, GH
Schwarzinger, I
Haas, OA
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems, ANN HEMATOL, 80(5), 2001, pp. 272-277
Authors:
Keil, F
Prinz, F
Kalhs, P
Lechner, K
Moser, K
Schwarzinger, I
Jager, U
Fonatsch, C
Worel, N
Mannhalter, C
Rabitsch, W
Loidolt, H
Schulenburg, A
Mitterbauer, M
Hocker, P
Greinix, HT
Citation: F. Keil et al., Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants, LEUKEMIA, 15(3), 2001, pp. 355-361
Authors:
Jahns-Streubel, G
Braess, J
Schoch, C
Fonatsch, C
Haase, D
Binder, C
Wormann, B
Buchner, T
Hiddemann, W
Citation: G. Jahns-streubel et al., Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF, LEUKEMIA, 15(3), 2001, pp. 377-384
Authors:
Wieser, R
Schreiner, U
Wollenberg, B
Neubauer, A
Fonatsch, C
Rieder, H
Citation: R. Wieser et al., Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia, HAEMATOLOG, 86(2), 2001, pp. 214-215
Authors:
Streubel, B
Valent, P
Lechner, K
Fonatsch, C
Citation: B. Streubel et al., Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21, CANC GENET, 124(1), 2001, pp. 42-46
Authors:
Wimazal, F
Sperr, WR
Kundi, M
Meidlinger, P
Fonatsch, C
Jordan, JH
Thalhammer-Scherrer, R
Schwarzinger, I
Geissler, K
Lechner, K
Valent, P
Citation: F. Wimazal et al., Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes, LEUK RES, 25(4), 2001, pp. 287-294
Authors:
Vinatzer, U
Taplick, J
Seiser, C
Fonatsch, C
Wieser, R
Citation: U. Vinatzer et al., The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 represstranscription and interact with histone deacetylase, BR J HAEM, 114(3), 2001, pp. 566-573
Authors:
Ohler, L
Berer, A
Aletaha, D
Kabrna, E
Heinze, G
Streubel, B
Fonatsch, C
Haas, OA
Lechner, K
Geissler, K
Citation: L. Ohler et al., Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth, BR J HAEM, 113(1), 2001, pp. 120-125
Authors:
Schoch, C
Haferlach, T
Haase, D
Fonatsch, C
Loffler, H
Schlegelberger, B
Staib, P
Sauerland, MC
Heinecke, A
Buchner, T
Hiddemann, W
Citation: C. Schoch et al., Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients, BR J HAEM, 112(1), 2001, pp. 118-126
Authors:
Staratschek-Jox, A
Thomas, RK
Zander, T
Massoudi, N
Kornacker, M
Bullerdiek, J
Fonatsch, C
Diehl, V
Wolf, J
Citation: A. Staratschek-jox et al., Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236, BR J CANC, 84(3), 2001, pp. 381-387
Authors:
Dreyling, MH
Schrader, K
Muschinsky, V
Fonatsch, C
Schlegelberger, B
Haase, D
Schoch, C
Ludwig, WD
Hiddemann, W
Bohlander, SK
Citation: Mh. Dreyling et al., Molecular characterization of the translocation (10;11)(p13;q14): MLL and CALM are fused to AF10 in morphologically different subsets of acute leukemia, HEMAT BLOOD, 40, 2001, pp. 20-26
Authors:
Mitterbauer, M
Laczika, K
Novak, M
Mitterbauer, G
Hilgarth, B
Pirc-Danoewinata, H
Schwarzinger, I
Haas, OA
Fonatsch, C
Lechner, K
Jaeger, U
Citation: M. Mitterbauer et al., High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia - A single center study, AM J CLIN P, 113(3), 2000, pp. 406-410
Authors:
Streubel, B
Valent, P
Jager, U
Edelhauser, M
Wandt, H
Wagner, T
Buchner, T
Lechner, K
Fonatsch, C
Citation: B. Streubel et al., Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome, GENE CHROM, 27(4), 2000, pp. 380-386
Authors:
Reiter, E
Greinix, H
Rabitsch, W
Keil, F
Schwarzinger, I
Jaeger, U
Lechner, K
Worel, N
Streubel, B
Fonatsch, C
Mitterbauer, G
Kalhs, P
Citation: E. Reiter et al., Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26), ANN HEMATOL, 79(7), 2000, pp. 374-377
Authors:
Greinix, HT
Loidolt, H
Rabitsch, W
Schulenburg, A
Keil, F
Mitterbauer, M
Laczika, K
Lechner, K
Dieckmann, K
Fischer, G
Jager, U
Rosenmayr, A
Knobl, P
Schwarzinger, I
Hocker, P
Mannhalter, C
Hinterberger, W
Haas, OA
Fonatsch, C
Kalhs, P
Citation: Ht. Greinix et al., Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia, ANN HEMATOL, 79(4), 2000, pp. 206-213
Authors:
Lengfelder, E
Reichert, A
Schoch, C
Haase, D
Haferlach, T
Loffler, H
Staib, P
Heyll, A
Seifarth, W
Saussele, S
Fonatsch, C
Gassmann, W
Ludwig, WD
Hochhaus, A
Beelen, D
Aul, C
Sauerland, MC
Heinecke, A
Hehlmann, R
Wormann, B
Hiddemann, W
Buchner, T
Citation: E. Lengfelder et al., Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1362-1370
Authors:
Stoiser, B
Knobl, P
Fonatsch, C
Haas, OA
Mitterbauer, G
Weltermann, A
Geissler, K
Valent, P
Sperr, W
Pabinger, I
Lechner, K
Jaeger, U
Citation: B. Stoiser et al., Prognosis of patients with a second relapse of acute myeloid leukemia, LEUKEMIA, 14(12), 2000, pp. 2059-2063
Authors:
Filipits, M
Stranzl, T
Pohl, G
Heinzl, H
Jager, U
Geissler, K
Fonatsch, C
Haas, OA
Lechner, K
Pirker, R
Citation: M. Filipits et al., Drug resistance factors in acute myeloid leukemia: a comparative analysis, LEUKEMIA, 14(1), 2000, pp. 68-76
Authors:
Bohlander, SK
Muschinsky, V
Schrader, K
Siebert, R
Schlegelberger, B
Harder, L
Schemmel, V
Fonatsch, C
Ludwig, WD
Hiddemann, W
Dreyling, MH
Citation: Sk. Bohlander et al., Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients, LEUKEMIA, 14(1), 2000, pp. 93-99
Authors:
Wimmer, K
Eckart, M
Rehder, H
Fonatsch, C
Citation: K. Wimmer et al., Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients, HUM GENET, 106(3), 2000, pp. 311-313
Authors:
Apfelbeck, U
Hoefler, G
Neumeister, P
Fonatsch, C
Linkesch, W
Sill, H
Citation: U. Apfelbeck et al., Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation, BONE MAR TR, 26(10), 2000, pp. 1111-1112
Authors:
Edelhauser, M
Raber, W
Mitterbauer, G
Mannhalter, C
Lechner, K
Fonatsch, C
Citation: M. Edelhauser et al., Variant intra Philadelphia translocation with rearrangement of BCR-ABL andABL-BCR within the same chromosome in a patient with cALL, CANC GENET, 122(2), 2000, pp. 83-86